arsenic has been researched along with 8-((4-chlorophenyl)thio)cyclic-3',5'-amp in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, X; Chen, SJ; Chen, Z; Flexor, M; Jia, PM; Lanotte, M; Shen, YL; Tong, JH; Waxman, S; Yu, Y; Zhang, JW; Zhu, HQ; Zhu, Q | 1 |
Chen, GQ; Chen, SJ; Chen, Z; Jia, PM; Tong, JH; Wang, ZY; Yu, Y; Zhu, Q | 1 |
Cai, X; Chen, SJ; Chen, Z; Jia, PM; Tong, JH; Wang, ZY; Yu, Y; Zhu, Q | 1 |
Harvey, RD; Sims, C | 1 |
4 other study(ies) available for arsenic and 8-((4-chlorophenyl)thio)cyclic-3',5'-amp
Article | Year |
---|---|
Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Division; Cyclic AMP; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Receptor Cross-Talk; Signal Transduction; Thionucleotides; Tumor Cells, Cultured | 2002 |
[Experimental study of low dose arsenic trioxide in treatment of patients with acute promyelocytic leukemia].
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Isoquinolines; Leukemia, Promyelocytic, Acute; Oxides; Sulfonamides; Thionucleotides; Tumor Cells, Cultured | 2002 |
[In vitro study of the effects of arsenic trioxide combined with 8-CPT-cAMP on differentiation induction in retinoic acid resistant acute promyelocytic leukemia cells].
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tumor; Cyclic AMP; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Oxides; Thionucleotides; Tretinoin | 2003 |
Redox modulation of basal and beta-adrenergically stimulated cardiac L-type Ca(2+) channel activity by phenylarsine oxide.
Topics: Animals; Arsenicals; Calcium; Calcium Channels, L-Type; Colforsin; Cyclic AMP; Dithiothreitol; Drug Evaluation, Preclinical; Electrophysiology; Guinea Pigs; Isoproterenol; Myocytes, Cardiac; Oxidation-Reduction; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Receptors, Adrenergic, beta; Signal Transduction; Thionucleotides; Time Factors | 2004 |